Aton Ra Partners Emergent Bio Solutions Inc. Transaction History

Aton Ra Partners

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $315,467 - $501,963	-11,505 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $90,215 - $129,140	-2,473 Reduced 17.69%	11,505 $472,000
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $17,912 - $29,760	-541 Reduced 3.73%	13,978 $608,000
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $20,278 - $26,750	405 Added 2.87%	14,519 $727,000
Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $77,046 - $109,506	-1,361 Reduced 8.79%	14,114 $889,000

Q1 2021 May 17, 2021	BUY	$86.23 - $125.19 $289,301 - $420,012	3,355 Added 27.68%	15,475 $1.44 Million
Q4 2020 Feb 19, 2021	BUY	$79.17 - $111.47 $959,540 - $1.35 Million	12,120 New	12,120 $1.09 Million

136

35.6M

78.7K

75.1K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $376M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.